BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2285819)

  • 1. Improvement of continuous arteriovenous hemofiltration (CAVH) and hemofiltration (HF) efficiency by adding hemoperfusion (HP).
    Marangoni R; Civardi F; Masi F; Avanzi C; Savino R; Manfredi A; Cimino R
    Biomater Artif Cells Artif Organs; 1990; 18(4):541-8. PubMed ID: 2285819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paired filtration-dialysis (PFD): a separate convective-diffusive system for extracorporeal blood purification in uraemic patients.
    Ghezzi PM; Zucchelli P; Ringoir S; Nigrelli S; Santoro A; Gervasio R; Sanz Moreno C; Vanholder R; Botella J
    Adv Exp Med Biol; 1987; 223():267-75. PubMed ID: 3328955
    [No Abstract]   [Full Text] [Related]  

  • 3. Our experience with combined hemodialysis-hemoperfusion treatment in chronic uremia.
    Splendiani G; Albano V; Tancredi M; Daniele M; Pignatelli F
    Biomater Artif Cells Artif Organs; 1987; 15(1):175-81. PubMed ID: 3449135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A purification method by uncoated charcoal.
    Cerulli N; Politi L; D'Angelo AR; Scandurra R
    Adv Exp Med Biol; 1987; 223():193-6. PubMed ID: 3447435
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical aspects and applications of hemofiltration.
    Weiss LG
    Scand J Urol Nephrol Suppl; 1989; 118():1-64. PubMed ID: 2785286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates.
    Brunet S; Leblanc M; Geadah D; Parent D; Courteau S; Cardinal J
    Am J Kidney Dis; 1999 Sep; 34(3):486-92. PubMed ID: 10469859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemofiltration and hemoperfusion performed in series for the purpose of removing beta 2 microglobulin].
    Marangoni R; Civardi F; Savino R; Manfredi A; Masi F; Avanzi C; Lino S
    Cas Lek Cesk; 1989 Sep; 128(39):1217-20. PubMed ID: 2684408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aluminum removal with hemodialysis, hemofiltration and charcoal hemoperfusion in uremic patients after desferrioxamine infusion. A comparison of efficiency.
    Weiss LG; Danielson BG; Fellström B; Wikström B
    Nephron; 1989; 51(3):325-9. PubMed ID: 2918944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Removal of endogenous middle molecules by hemoperfusion.
    Asaba H; Bergström J; Fürst P; Gunnarsson B; Neuhauser M; Oulès R; Yahiel V
    Artif Organs; 1979 May; 3(2):132-6. PubMed ID: 533396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effectiveness of sustained low-efficiency hemodialysis plus hemoperfusion and continuous hemofiltration plus hemoperfusion for acute severe organophosphate poisoning.
    Hu SL; Wang D; Jiang H; Lei QF; Zhu XH; Cheng JZ
    Artif Organs; 2014 Feb; 38(2):121-4. PubMed ID: 23957329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated hemoperfusion and continuous arteriovenous hemofiltration in a paraquat poisoned patient.
    Pond SM; Johnston SC; Schoof DD; Hampson EC; Bowles M; Wright DM; Petrie JJ
    J Toxicol Clin Toxicol; 1987; 25(4):305-16. PubMed ID: 3669116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The removal of uremic small and middle molecules and free amino acids by carbon hemoperfusion.
    Oulès R; Asaba H; Neuhäuser M; Yahiel V; Gunnarsson B; Bergström J; Fürst P
    Trans Am Soc Artif Intern Organs; 1977; 23():583-90. PubMed ID: 910385
    [No Abstract]   [Full Text] [Related]  

  • 13. Principles and practice of hemofiltration and hemodiafiltration.
    Ledebo I
    Artif Organs; 1998 Jan; 22(1):20-5. PubMed ID: 9456222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convective therapies for removal of middle molecular weight uremic toxins in end-stage renal disease: a review of the evidence.
    Thomas G; Jaber BL
    Semin Dial; 2009; 22(6):610-4. PubMed ID: 20017830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemoperfusion results in uremia.
    Gelfand MC; Winchester JF
    Clin Nephrol; 1979 Feb; 11(2):107-10. PubMed ID: 378488
    [No Abstract]   [Full Text] [Related]  

  • 16. Effective removal of protein-bound uraemic solutes by different convective strategies: a prospective trial.
    Meert N; Eloot S; Waterloos MA; Van Landschoot M; Dhondt A; Glorieux G; Ledebo I; Vanholder R
    Nephrol Dial Transplant; 2009 Feb; 24(2):562-70. PubMed ID: 18809977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clearance studies in patients with acute renal failure treated by continuous arteriovenous haemodialysis.
    Davies SP; Kox WJ; Brown EA
    Contrib Nephrol; 1991; 93():117-9. PubMed ID: 1802558
    [No Abstract]   [Full Text] [Related]  

  • 18. Convective and adsorptive removal of beta2-microglobulin during predilutional and postdilutional hemofiltration.
    Padrini R; Canova C; Conz P; Mancini E; Rizzioli E; Santoro A
    Kidney Int; 2005 Nov; 68(5):2331-7. PubMed ID: 16221237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential convective therapies (SCT): a prospective study on feasibility, safety, adequacy and tolerance of on-line hemofiltration and hemodiafiltration in sequence.
    Petras D; Fortunato A; Soffiati G; Brendolan A; Bonello M; Crepaldi C; Ratanarat R; Campolo G; Amato M; Ronco C
    Int J Artif Organs; 2005 May; 28(5):482-8. PubMed ID: 15883963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemofiltration in acute kidney failure. Experiences of a surgical intensive care station].
    List WF; Kulier A; Kiesling A; Semu J
    Anaesthesist; 1990 Oct; 39(10):540-6. PubMed ID: 2278375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.